Cargando…

Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?

Inherited metabolic diseases (IMDs) are rare heterogenous genetic conditions. Advanced technology and novel therapeutic developments have led to the improved life expectancy of patients with IMDs. Long-term, they require close surveillance from specialist adult metabolic providers. Healthcare transi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Jessica I., Stepien, Karolina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572070/
https://www.ncbi.nlm.nih.gov/pubmed/36233672
http://dx.doi.org/10.3390/jcm11195805
_version_ 1784810521970606080
author Gold, Jessica I.
Stepien, Karolina M.
author_facet Gold, Jessica I.
Stepien, Karolina M.
author_sort Gold, Jessica I.
collection PubMed
description Inherited metabolic diseases (IMDs) are rare heterogenous genetic conditions. Advanced technology and novel therapeutic developments have led to the improved life expectancy of patients with IMDs. Long-term, they require close surveillance from specialist adult metabolic providers. Healthcare transition (HCT) is the planned, purposeful process of preparing adolescents for adult-centered medical care and has been recognized globally as a necessary component of care for IMDs. Two recent surveys outlined barriers to the HCT in the US and the UK. The limited knowledge of IMDs among adult physicians was one of the barriers. Some work on specialty curriculum has started and aims to improve the structured training and awareness of rare diseases. Other barriers included social and legal aspects of adulthood, social, vocational and educational support for young adults, care fragmentation and insurance coverage. Although various HCT tools are available, they cannot always be standardized for IMDs. Despite the remarkable differences in the healthcare systems and physicians’ training, collaboration among metabolic centers is possible. International rare disease alliance may enhance the patients’ management via guidelines development and standardized training for adult metabolic providers.
format Online
Article
Text
id pubmed-9572070
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95720702022-10-17 Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible? Gold, Jessica I. Stepien, Karolina M. J Clin Med Review Inherited metabolic diseases (IMDs) are rare heterogenous genetic conditions. Advanced technology and novel therapeutic developments have led to the improved life expectancy of patients with IMDs. Long-term, they require close surveillance from specialist adult metabolic providers. Healthcare transition (HCT) is the planned, purposeful process of preparing adolescents for adult-centered medical care and has been recognized globally as a necessary component of care for IMDs. Two recent surveys outlined barriers to the HCT in the US and the UK. The limited knowledge of IMDs among adult physicians was one of the barriers. Some work on specialty curriculum has started and aims to improve the structured training and awareness of rare diseases. Other barriers included social and legal aspects of adulthood, social, vocational and educational support for young adults, care fragmentation and insurance coverage. Although various HCT tools are available, they cannot always be standardized for IMDs. Despite the remarkable differences in the healthcare systems and physicians’ training, collaboration among metabolic centers is possible. International rare disease alliance may enhance the patients’ management via guidelines development and standardized training for adult metabolic providers. MDPI 2022-09-30 /pmc/articles/PMC9572070/ /pubmed/36233672 http://dx.doi.org/10.3390/jcm11195805 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gold, Jessica I.
Stepien, Karolina M.
Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_full Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_fullStr Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_full_unstemmed Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_short Healthcare Transition in Inherited Metabolic Disorders—Is a Collaborative Approach between US and European Centers Possible?
title_sort healthcare transition in inherited metabolic disorders—is a collaborative approach between us and european centers possible?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572070/
https://www.ncbi.nlm.nih.gov/pubmed/36233672
http://dx.doi.org/10.3390/jcm11195805
work_keys_str_mv AT goldjessicai healthcaretransitionininheritedmetabolicdisordersisacollaborativeapproachbetweenusandeuropeancenterspossible
AT stepienkarolinam healthcaretransitionininheritedmetabolicdisordersisacollaborativeapproachbetweenusandeuropeancenterspossible